New weapon against aggressive prostate cancer enters human testing

NCT ID NCT06842498

Recruiting now Disease control Sponsor: Kyntra Bio Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called FG-3246 for men with metastatic prostate cancer that has stopped responding to standard hormone treatments. The trial aims to find the best dose and see how well the drug works at slowing cancer growth and controlling symptoms. About 75 participants will receive the experimental treatment to evaluate its safety and effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bioresearch Partner
RECRUITING

Aventura, Florida, 33180, United States
Bioresearch Partner
RECRUITING

Hialeah, Florida, 33013, United States
Carolina Urologic Research Center
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Duke University Medical Center - Duke Cancer Center
RECRUITING

Durham, North Carolina, 27710, United States
Fred Hutchinson Cancer Center
RECRUITING

Seattle, Washington, 98109, United States
New Mexico Oncology Hematology Consultants, Ltd.
RECRUITING

Albuquerque, New Mexico, 87109, United States
Oncology Consultants
RECRUITING

Houston, Texas, 77030, United States
The University of Arizona Cancer Center - North Campus
RECRUITING

Tucson, Arizona, 85719, United States
UCLA Clark Urology Center
RECRUITING

Los Angeles, California, 90095, United States
UNC Hospitals, The University of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27514, United States
University Hospitals Cleveland Medical Center
RECRUITING

Cleveland, Ohio, 44106, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94143, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
University of Virginia Comprehensive Cancer Center
RECRUITING

Charlottesville, Virginia, 22903, United States
Winship Cancer Institute, Emory University
RECRUITING

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION RESISTANT PROSTATE CANCER